Folate-targeted surface-enhanced resonance raman scattering nanoprobe ratiometry for detection of microscopic ovarian cancer Journal Article
| Authors: | Oseledchyk, A.; Andreou, C.; Wall, M. A.; Kircher, M. F. |
| Article Title: | Folate-targeted surface-enhanced resonance raman scattering nanoprobe ratiometry for detection of microscopic ovarian cancer |
| Abstract: | Ovarian cancer has a unique pattern of metastatic spread, in that it initially spreads locally within the peritoneal cavity. This is in contrast to most other cancer types, which metastasize early on via the bloodstream to distant sites. This unique behavior opens up an opportunity for local application of both therapeutic and imaging agents. Upon initial diagnosis, 75% of patients already present with diffuse peritoneal spread involving abdominal organs. Complete resection of all tumor implants has been shown to be a major factor for improved survival. Unfortunately, it is currently not possible for surgeons to visualize microscopic implants, impeding their removal and leading to tumor recurrences and poor outcomes in most patients. Thus, there is a great need for new intraoperative imaging techniques that can overcome this hurdle. We devised a method that employs folate receptor (FR)-targeted surface-enhanced resonance Raman scattering (SERRS) nanoparticles (NPs), as folate receptors are typically overexpressed in ovarian cancer. We report a robust ratiometric imaging approach using anti-FR-SERRS-NPs (alpha FR-NPs) and nontargeted SERRS-NPs (nt-NPs) multiplexing. We term this method "topically applied surface-enhanced resonance Raman ratiometric spectroscopy" (TAS3RS ("tasers") for short). TAS3RS successfully enabled the detection of tumor lesions in a murine model of human ovarian adenocarcinoma regardless of their size or localization. Tumors as small as 370 mu m were detected, as confirmed by bioluminescence imaging and histological staining. TAS3RS holds promise for intraoperative detection of microscopic residual tumors and could reduce recurrence rates in ovarian cancer and other diseases with peritoneal spread. |
| Keywords: | chemotherapy; ovarian cancer; surgical cytoreduction; molecular imaging; tumors; nanoparticles; in-vivo; nanoparticle; receptor; sensitivity; strategy; modality; sers; raman |
| Journal Title: | ACS Nano |
| Volume: | 11 |
| Issue: | 2 |
| ISSN: | 1936-0851 |
| Publisher: | American Chemical Society |
| Date Published: | 2017-02-28 |
| Start Page: | 1488 |
| End Page: | 1497 |
| Language: | English |
| ACCESSION: | WOS:000395357300039 |
| DOI: | 10.1021/acsnano.6b06796 |
| PROVIDER: | wos |
| PUBMED: | 27992724 |
| PMCID: | PMC5502101 |
| Notes: | Article -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
-
55Kircher -
10Wall -
16Oseledchyk -
22Andreou
Related MSK Work